响应pH的异基抗瘤聚合物结合物通过自我组装和内体向抗癌活性提供更高的药物负载
Camilla Passi1,2,3, Tobias Neu2,3,4, Nicole Schneider-Daum4
1Department of Pharmacy, Pharmaceutical Materials and Processing, Saarland University, Campus C4 1, 66123, Saarbrücken, Germany.
ChemMedChem
|January 31, 2026
概括
这项研究开发了一种用于癌症治疗的新型聚合物-药物合物 (PDC). 法尔纳斯-聚-L-氨酸合物 (Far-PL) 显示了增强的癌细胞杀死和降低毒性,提供了一个有前途的新治疗平台.
科学领域:
- 生物结合化学 生物结合化学
- 聚合物科学 聚合物科学
- 纳米医学是一种纳米医学.
背景情况:
- 聚合物药物合物 (PDCs) 改善了癌症治疗中难溶性药物的输送.
- 刺激响应链接器使瘤微环境中的药物释放得到控制.
- 聚-L-lysine (PL) 和farnesal (Far) 是具有抗癌性能的生物相容化合物.
研究的目的:
- 设计和合成一个新的,无链接剂的聚合物-药物联合体 (PDC) 的farnesal (Far) 和Poly-L-Lysine (PL).
- 为了评估pH响应药物释放,自组装成纳米颗粒,以及Far-PL结合物的体外抗癌疗效.
主要方法:
- 通过一条 imine 键将法内萨尔与聚-L-lysine 的结合.
- 评估pH取决于药物释放的情况.
- 自组装纳米粒子的表征 (大小,电荷,药物负载).
- 在A549肺癌细胞和Arlo非癌细胞的体外细胞毒性测定.
主要成果:
- Far-PL结合物表现出响应pH的药物释放,在生理pH下稳定,在酸性瘤 (pH6.5) 和内体 (pH5.5) 条件下释放.
- 远PL自组装成具有正表面电荷,狭窄尺寸分布和100%药物含量的稳定纳米粒子.
- 与单个成分相比,结合物对A549肺癌细胞具有增强的细胞毒性.
- 在非癌性Arlo细胞中观察到毒性降低,表明瘤选择性得到改善.
结论:
- 这种新型的无链接器Far-PL合物是针对性癌症治疗的有希望的平台.
- 它的pH响应性药物释放和纳米粒子自组装可以提高治疗效果,同时最大限度地降低系统毒性.
- 这种PDC设计为改善癌症治疗结果提供了一个潜在的策略.
相关概念视频
02:34Polymers
40.9K
The word polymer is derived from the Greek words “poly” which means “many” and “mer” which means “parts”. Polymers are long chains of molecules composed of repeating units of smaller molecules, known as monomers. They either occur naturally, such as DNA and proteins, or can be constructed synthetically, like plastics. They have varied structural characteristics, such as linear chains, branched chains, or complex networks, that contribute to the...
40.9K
01:28Maturation of Endosomes
5.8K
The early endosome containing internalized molecules matures through transformations in its location, morphology, intraluminal pH, and membrane protein composition. Together, these changes result in a more acidic late endosome that contains multiple intraluminal vesicles; therefore, the late endosome is also called a multivesicular body (MVB).
Changes in location
The maturing endosome moves along microtubules from the periphery of the cell towards the perinuclear region. This movement of the...
Changes in location
The maturing endosome moves along microtubules from the periphery of the cell towards the perinuclear region. This movement of the...
5.8K
01:22Target Cell Response to Hormones
5.7K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.7K
01:26Targets for Drug Action: Overview
10.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.3K
02:50Conjugated Proteins
28.7K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
28.7K
01:28The Early Endosome: Endocytosis of Transferrin
4.8K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.8K